RxDoctor Payments Data

Edward Aull

Developmental - Behavioral Pediatrics · Carmel, INNPI 1922009786

Payments from drug & device makers

$20,006in general payments, 2019–2025

Across 204 payments — averaging $98.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$18K
  • Jazz Pharmaceuticals Inc.$464
  • Corium, LLC$321
  • Ironshore Pharmaceuticals Inc.$317
  • Sunovion Pharmaceuticals Inc.$231
  • Collegium Pharmaceutical, Inc.$106
  • plus $354 from 8 others

What the payments were for

  • Speaking & faculty fees$15,90079%
  • Travel & lodging$9055%
  • Food & beverage$3,12616%
  • Education$750%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few developmental - behavioral pediatrics providers in Indianato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Paliperidone ErPaliperidone24$11,289
Aripiprazole24$11,061
VyvanseLisdexamfetamine Dimesylate12$4,237
Atomoxetine Hcl34$4,095
Fluoxetine Hcl54$3,386
Imipramine Hcl15$2,090
Quetiapine Fumarate33$1,237
Clonidine Hcl20$318
Trazodone Hcl17$249
Metformin Hcl ErMetformin Hcl21$220
Sertraline Hcl15$166

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$85$4,23712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few developmental - behavioral pediatrics providers in Indianaon file to place this against a meaningful peer group, so we don't.

Other developmental - behavioral pediatrics in Carmel

Where these figures come from

Is this you, or does something look wrong? →